相关实验视频

Updated: Jul 2, 2025

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

机器学习将T细胞功能和空间定位与新辅助免疫疗法和胰腺癌的临床结果联系起来

Katie E Blise^1,2, Shamilene Sivagnanam^2,3, Courtney B Betts^2,3,4

¹Department of Biomedical Engineering, Oregon Health and Science University, Portland, Oregon.

Cancer immunology research

|February 21, 2024

概括

机器学习 (ML) 分析了复杂的胰腺癌数据,揭示了抗CD40疗法如何影响T细胞并改善无疾病生存率 (DFS). 在ML中确定了与胰腺管腺癌 (PDAC) 患者更好的结果相关的特定T细胞.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
计算生物学计算生物学

背景情况:

瘤分子数据的复杂性挑战了人类的分析.
机器学习 (ML) 提供了一种强大的方法来剖析复杂的癌症数据集.
了解瘤微环境 (TME) 对于预测治疗反应至关重要.

研究的目的:

将ML应用于胰腺癌的复杂蛋白质组数据集.
研究抗CD40治疗对T细胞功能和TME内的空间定位的影响.
在胰腺管腺癌 (PDAC) 患者中确定ML衍生生物标志物预测无疾病生存 (DFS).

主要方法:

利用多重免疫组织化学分析PDAC瘤中的T细胞特征,从未接受过治疗的患者和接受过抗CD40治疗的患者.
量化了来自306个组织区域近250万个细胞的1000多个TME特征.
训练有素的ML模型根据TME特征预测抗CD40治疗状态和DFS.

主要成果:

ML模型准确地预测了抗CD40治疗状态和DFS.
抗CD40疗法被证明可以减少T细胞在TME中的耗尽.
改善的DFS与特定免疫聚合区的CD44+CD4+Th1细胞增加相关.

结论:

ML是分子癌症免疫学和TME分析的宝贵工具.
抗CD40疗法调节胰腺癌TME中的T细胞反应.
特定的T细胞种群及其空间背景可以作为PDAC中抗CD40治疗的预测生物标志物.

更多相关视频

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

Immunophenotyping of Orthotopic Homograft Syngeneic of Murine Primary KPC Pancreatic Ductal Adenocarcinoma by Flow Cytometry

Immunophenotyping of Orthotopic Homograft Syngeneic of Murine Primary KPC Pancreatic Ductal Adenocarcinoma by Flow Cytometry

Published on: October 9, 2018

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.